CCMG
WST icon

Clark Capital Management Group’s West Pharmaceutical WST Stock Holding History

Clark Capital Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,797
Closed -$280K – 383
2013
Q3 		$280K Sell
6,797
-879
-11% -$33.5K 0.02% 287
2013
Q2 		$270K Buy
+7,676
New +$253K 0.02% 271

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clark Capital Management Group's WST Position: Q4 2013 in Review

Clark Capital Management Group sold out of West Pharmaceutical (WST) in Q4 2013, closing a stake of 6,797 shares — an estimated $280K sold.

Clark Capital Management Group first reported a position in WST in Q2 2013 and held it in 2 quarters. The position peaked at $280K in Q3 2013. 230 funds tracked by Wall St. Rank hold WST as of Q4 2013.

  • Clark Capital Management Group reported no remaining West Pharmaceutical position as of Q4 2013 after selling out during the quarter.
  • Clark Capital Management Group sold 6,797 West Pharmaceutical shares in Q4 2013, an estimated $280K.
  • Clark Capital Management Group first reported a position in West Pharmaceutical in Q2 2013 and held it in 2 quarters.
  • Clark Capital Management Group's West Pharmaceutical position peaked at $280K in Q3 2013.
  • 230 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2013.

Based on Clark Capital Management Group's 13F filing for Q4 2013, filed 6 Feb 2014.